<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03407898</url>
  </required_header>
  <id_info>
    <org_study_id>20-1006-16</org_study_id>
    <nct_id>NCT03407898</nct_id>
  </id_info>
  <brief_title>The Effect of Different Videolaryngoscopes on Intubation Success in Difficult Airway Patients</brief_title>
  <official_title>The Effect of Different Videolaryngoscopes on Intubation Success in Difficult Airway Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mallampati score &gt; 3 generally indicate difficult airway and difficult intubation. Most
      anesthesiologist usually use this score system to predict difficult airway management.
      Different laryngoscopes may be useful in management of difficult airway. This study designed
      to compare different videolaryngoscopes in intubation success in patient of Mallampati
      score&gt;3.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2018</start_date>
  <completion_date type="Actual">November 1, 2018</completion_date>
  <primary_completion_date type="Actual">September 1, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>intubation time</measure>
    <time_frame>60 seconds</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">130</enrollment>
  <condition>Mallampati Score, Difficult Intubation, Videolaryngoscope</condition>
  <arm_group>
    <arm_group_label>C-mac D blade used for intubation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>mcgrath X blade used for intubation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intubation time</intervention_name>
    <description>intubation attempt number and intubation time</description>
    <arm_group_label>C-mac D blade used for intubation</arm_group_label>
    <arm_group_label>mcgrath X blade used for intubation</arm_group_label>
    <other_name>intubation attempt</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients who has mallampati score &gt;3
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mallampati score &gt;3

        Exclusion Criteria:

          -  patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CIGDEM YILDIRIMGUCLU</last_name>
    <role>Study Chair</role>
    <affiliation>Ankara University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cigdem Yildirimguclu</name>
      <address>
        <city>Ankara</city>
        <zip>06550</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 17, 2018</study_first_submitted>
  <study_first_submitted_qc>January 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>February 27, 2020</last_update_submitted>
  <last_update_submitted_qc>February 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>CIGDEM YILDIRIM GUCLU</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

